An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Open Label ◽

Multicenter Clinical Study

An open label, multicenter clinical study of cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: Preliminary results of a phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e14520 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e14520-e14520 ◽

Author(s):

J. M. Yu ◽

J. H. Wang ◽

X. Sun ◽

L. H. Wang ◽

G. Y. Zhu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Study ◽

Cell Carcinoma ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Locally Advanced ◽

Open Label ◽

Multicenter Clinical Study

Single-arm, Open-label, Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Case Medical Research ◽

10.31525/ct1-nct03917966 ◽

2019 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Preoperative Chemotherapy ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Open Label ◽

Open Label Phase

Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.512 ◽

2011 ◽

Vol 81 (2) ◽

pp. S315-S316

Author(s):

J. Yu ◽

J. Wang ◽

X. Sun ◽

L. Wang ◽

M. Ye ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Chinese Patients ◽

Open Label ◽

Multicenter Phase

A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)

Annals of Oncology ◽

10.1093/annonc/mdz266.018 ◽

2019 ◽

Vol 30 ◽

pp. v754 ◽

Author(s):

S. Lee ◽

B.C. Ahn ◽

S.Y. Park ◽

D.J. Kim ◽

C.G. Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Preoperative Chemoradiotherapy

166TiP Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)

Annals of Oncology ◽

10.1016/j.annonc.2021.10.185 ◽

2021 ◽

Vol 32 ◽

pp. S1454-S1455

Author(s):

H. Jiang ◽

X. Shang ◽

C. Zhang ◽

J. Yue ◽

X. Duan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Study ◽

Neoadjuvant Chemotherapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Neoadjuvant Chemoradiotherapy ◽

Phase Iii ◽

Randomized Controlled

65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research

Annals of Oncology ◽

10.1016/j.annonc.2021.10.083 ◽

2021 ◽

Vol 32 ◽

pp. S1400

Author(s):

J. Ma ◽

J. Zhang ◽

Y. Yang ◽

D. Zheng ◽

X. Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Exploratory Research

Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3052-4 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1315-1319 ◽

Cited By ~ 3

Author(s):

Goshi Nishimura ◽

Takahide Taguchi ◽

Masahiro Takahashi ◽

Osamu Shiono ◽

Masanori Komatsu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head

Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma

Diseases of the Esophagus ◽

10.1093/dote/doz013 ◽

2019 ◽

Author(s):

X-W Cai ◽

Y Zeng ◽

W Feng ◽

M-N Liu ◽

W Yu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Postoperative Radiotherapy ◽

Tumor Bed ◽

Randomized Phase Ii

A Phase II Trial of Adjuvant Cetuximab and Radiation Therapy in Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.285 ◽

2020 ◽

Vol 108 (3) ◽

pp. e800

Author(s):

P.J. Kreinbrink ◽

M.L. Mierzwa ◽

K.P. Redmond ◽

T. Wise-Draper ◽

K. Casper ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Cutaneous Squamous Cell Carcinoma

Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps6102 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS6102-TPS6102 ◽

Author(s):

Erminia Massarelli ◽

Robert I. Haddad ◽

J. Jack Lee ◽

Adam S. Garden ◽

George R. Blumenschein ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Randomized Phase Ii